Search Results - "Boye, Sanford"

Refine Results
  1. 1

    Current Clinical Applications of In Vivo Gene Therapy with AAVs by Mendell, Jerry R., Al-Zaidy, Samiah A., Rodino-Klapac, Louise R., Goodspeed, Kimberly, Gray, Steven J., Kay, Christine N., Boye, Sanford L., Boye, Shannon E., George, Lindsey A., Salabarria, Stephanie, Corti, Manuela, Byrne, Barry J., Tremblay, Jacques P.

    Published in Molecular therapy (03-02-2021)
    “…Hereditary diseases are caused by mutations in genes, and more than 7,000 rare diseases affect over 30 million Americans. For more than 30 years, hundreds of…”
    Get full text
    Journal Article
  2. 2

    Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors by Kay, Christine N, Ryals, Renee C, Aslanidi, George V, Min, Seok Hong, Ruan, Qing, Sun, Jingfen, Dyka, Frank M, Kasuga, Daniel, Ayala, Andrea E, Van Vliet, Kim, Agbandje-McKenna, Mavis, Hauswirth, William W, Boye, Sanford L, Boye, Shannon E

    Published in PloS one (26-04-2013)
    “…Development of viral vectors capable of transducing photoreceptors by less invasive methods than subretinal injection would provide a major advancement in…”
    Get full text
    Journal Article
  3. 3

    A Comprehensive Review of Retinal Gene Therapy by Boye, Shannon E, Boye, Sanford L, Lewin, Alfred S, Hauswirth, William W

    Published in Molecular therapy (01-03-2013)
    “…Blindness, although not life threatening, is a debilitating disorder for which few, if any treatments exist. Ocular gene therapies have the potential to…”
    Get full text
    Journal Article
  4. 4

    Complement C3-Targeted Gene Therapy Restricts Onset and Progression of Neurodegeneration in Chronic Mouse Glaucoma by Bosco, Alejandra, Anderson, Sarah R., Breen, Kevin T., Romero, Cesar O., Steele, Michael R., Chiodo, Vince A., Boye, Sanford L., Hauswirth, William W., Tomlinson, Stephen, Vetter, Monica L.

    Published in Molecular therapy (03-10-2018)
    “…Dysregulation of the complement system is implicated in neurodegeneration, including human and animal glaucoma. Optic nerve and retinal damage in glaucoma is…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Improving retinal vascular endothelial cell tropism through rational rAAV capsid design by Periasamy, Ramesh, Patel, Dwani D, Boye, Sanford L, Boye, Shannon E, Lipinski, Daniel M

    Published in PloS one (11-05-2023)
    “…Vascular endothelial cells (VEC) are essential for retinal homeostasis and their dysfunction underlies pathogenesis in diabetic retinopathy (DR) and exudative…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    AAV-mediated cone rescue in a naturally occurring mouse model of CNGA3-achromatopsia by Pang, Ji-jing, Deng, Wen-Tao, Dai, Xufeng, Lei, Bo, Everhart, Drew, Umino, Yumiko, Li, Jie, Zhang, Keqing, Mao, Song, Boye, Sanford L, Liu, Li, Chiodo, Vince A, Liu, Xuan, Shi, Wei, Tao, Ye, Chang, Bo, Hauswirth, William W

    Published in PloS one (11-04-2012)
    “…Achromatopsia is a rare autosomal recessive disorder which shows color blindness, severely impaired visual acuity, and extreme sensitivity to bright light…”
    Get full text
    Journal Article
  10. 10
  11. 11

    β-secretase 1 overexpression by AAV-mediated gene delivery prevents retina degeneration in a mouse model of age-related macular degeneration by Qi, Xiaoping, Francelin, Carolina, Mitter, Sayak, Boye, Sanford L., Gu, Hongmei, Quigley, Judith, Grant, Maria B., Boulton, Michael E.

    Published in Molecular therapy (05-07-2023)
    “…We reported previously that β-site amyloid precursor protein cleaving enzyme (BACE1) is strongly expressed in the normal retina and that BACE1−/− mice develop…”
    Get full text
    Journal Article
  12. 12

    SARM1 depletion rescues NMNAT1-dependent photoreceptor cell death and retinal degeneration by Sasaki, Yo, Kakita, Hiroki, Kubota, Shunsuke, Sene, Abdoulaye, Lee, Tae Jun, Ban, Norimitsu, Dong, Zhenyu, Lin, Joseph B, Boye, Sanford L, DiAntonio, Aaron, Boye, Shannon E, Apte, Rajendra S, Milbrandt, Jeffrey

    Published in eLife (27-10-2020)
    “…Leber congenital amaurosis type nine is an autosomal recessive retinopathy caused by mutations of the NAD synthesis enzyme NMNAT1. Despite the ubiquitous…”
    Get full text
    Journal Article
  13. 13

    Optimization of Capillary-Based Western Blotting for MYO7A by Calabro, Kaitlyn R, Boye, Sanford L, Boye, Shannon E

    “…Myosin VIIA (MYO7A)-associated Usher syndrome type 1B (USH1B) is a severe disorder that impacts the auditory, vestibular, and visual systems of affected…”
    Get more information
    Journal Article
  14. 14

    Small GTPases Rab8a and Rab11a Are Dispensable for Rhodopsin Transport in Mouse Photoreceptors by Ying, Guoxin, Gerstner, Cecilia D, Frederick, Jeanne M, Boye, Sanford L, Hauswirth, William W, Baehr, Wolfgang

    Published in PloS one (16-08-2016)
    “…Rab11a and Rab8a are ubiquitous small GTPases shown as required for rhodopsin transport in Xenopus laevis and zebrafish photoreceptors by dominant negative…”
    Get full text
    Journal Article
  15. 15

    Impact of Heparan Sulfate Binding on Transduction of Retina by Recombinant Adeno-Associated Virus Vectors by Boye, Sanford L, Bennett, Antonette, Scalabrino, Miranda L, McCullough, K Tyler, Van Vliet, Kim, Choudhury, Shreyasi, Ruan, Qing, Peterson, James, Agbandje-McKenna, Mavis, Boye, Shannon E

    Published in Journal of virology (01-04-2016)
    “…Adeno-associated viruses (AAVs) currently are being developed to efficiently transduce the retina following noninvasive, intravitreal (Ivt) injection. However,…”
    Get full text
    Journal Article
  16. 16
  17. 17
  18. 18

    SubILM Injection of AAV for Gene Delivery to the Retina by Gamlin, Paul D, Alexander, John J, Boye, Sanford L, Witherspoon, C Douglas, Boye, Shannon E

    “…Adeno-associated virus (AAV) has emerged as the vector of choice for delivering genes to the retina. Indeed, the first gene therapy to receive FDA approval in…”
    Get more information
    Journal Article
  19. 19
  20. 20

    Inhibitor of apoptosis-stimulating protein of p53 (iASPP) is required for neuronal survival after axonal injury by Wilson, Ariel M, Chiodo, Vince A, Boye, Sanford L, Brecha, Nicholas C, Hauswirth, William W, Di Polo, Adriana

    Published in PloS one (01-04-2014)
    “…The transcription factor p53 mediates the apoptosis of post-mitotic neurons exposed to a wide range of stress stimuli. The apoptotic activity of p53 is tightly…”
    Get full text
    Journal Article